Mdm2 and Crem are associated with glioma, leukemia, prostate cancer, chronic myeloid leukemia, and several other cancer pathways, whereas, Gsk3b is an antitumor gene associated with prostate cancer (Table S3). This evidence concerns the gene CREM and chronic myelogenous leukemia, BCR-ABL1 positive.